COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma

The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaitzsch, Erik, Passerini, Verena, Khatamzas, Elham, Strobl, Carolin D., Muenchhoff, Maximilian, Scherer, Clemens, Osterman, Andreas, Heide, Michael, Reischer, Anna, Subklewe, Marion, Leutbecher, Alexandra, Tast, Benjamin, Ruhle, Adrian, Weiglein, Tobias, Stecher, Stephanie-Susanne, Stemmler, Hans J., Dreyling, Martin, Girl, Philipp, Georgi, Enrico, Wölfel, Roman, Mateyka, Laura, D’Ippolito, Elvira, Schober, Kilian, Busch, Dirk H., Kager, Juliane, Spinner, Christoph D., Treiber, Matthias, Rasch, Sebastian, Lahmer, Tobias, Iakoubov, Roman, Schneider, Jochen, Protzer, Ulrike, Winter, Christof, Ruland, Jürgen, Quante, Michael, Keppler, Oliver T., von Bergwelt-Baildon, Michael, Hellmuth, Johannes, Weigert, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240782/
https://www.ncbi.nlm.nih.gov/pubmed/34235400
http://dx.doi.org/10.1097/HS9.0000000000000603

Ejemplares similares

Ejemplares similares